INTRODUCTION:

· Gout, a clinically distinct ailment, was identified by Egyptians more than 4650 years ago and later documented by Hippocarates and Plato. It is among the most common inflammatory arthropathies and a genuine crystal deposition disorder, directly linked to the presence of monosodium urate (MSU) crystals in joints and other tissues.¹

· Gout is a widespread inherited metabolic disorder stemming from abnormalities in purine metabolism or decreased uric acid excretion. It is characterized by hyperuricemia-associated inflammatory arthritis and falls under the category of metabolic rheumatism.

· Consequently, finding an effective gout treatment has garnered increasing attention and has become a top priority².

Definition of Gout:

Gout is a condition that results from an inflammatory reaction to urate crystal deposits in joints. At 37ºC, urate has a blood solubility of approximately 7mg/dl. The Japanese guideline for gout and hyperuricemia management defines hyperuricemia as a persistent serum urate level above 7.0mg/dl, regardless of sex. This definition is based on the solubility of urate.

Types of Gout:

Primary Gout:

This form stems from an inherent defect in purine metabolism. It comprises 95% of all cases and results from either excessive production or insufficient elimination of uric acid, or a combination of these factors. Primary gout frequently runs in families.

Secondary Gout:

This type is linked to an acquired condition (such as polycythemia vera, multiple myeloma, or certain leukemias) or medication use. It accounts for 5% of all gout cases.

Etiology:

Patient 1:

Case 1 was a 46-year-old man with symptoms of gout pain in joints, especially in the big toe of the bottom, along with pain in other joints of the upper extremities. With these problems came OPD. The opinion was verified by thorough physical, systemic examination with proper history and disquisition.

Patient 2:

Case 2 was a 48-year-old man with no notable history to mistrustfulness other arthritis a history of taking painkillers to relieve the symptoms. He came in OPD with signs and symptoms of Gout. Symptoms were set up bilaterally. The intensity of pain is more in the right great toe of bases. He has given the once history of gout 7- 8 times back. He took allopathic treatment.

Patient 3:

A 65-year-old female, identified as Patient 3, visited the outpatient department exhibiting symptoms of gout. The diagnosis was confirmed following a comprehensive skin, physical, and systemic examination. The patient displayed characteristic signs of gout in various sizes.³

I. Unalterable risk factors for gout:

1. Age:

Gout prevalence rises in direct correlation with age, suggesting that increased life expectancy in developed countries may contribute to higher gout rates. This is due to the condition's link with age-related illnesses (such as metabolic syndrome and hypertension) and treatments for these diseases (like thiazide diuretics).

2. Sex/coitus:

Clinically, gout is frequently considered a manly complaint. Although gout frequency has increased in both relations, among cases older than 65 times men have a fourfold lesserfrequence than women. still, gout in the seniors has a more equal coitus distribution, most likely reflecting the loss of the uricosuric effect of estrogen following the menopause.

II. Alterable gout risk factors:

1. Serum urate:

The most crucial risk factor for gout is the level of serum urate. A study conducted over 14.9 years, known as the Normative Aging Study followed 2046 initially healthy participants. Those with initial serum urate levels of 9 mg/dl or higher experienced a 22% cumulative incidence of gout within a 6-year timeframe.

2. Specifics:

Colorful specifics are linked to gout, including diuretics (mentioned before), low-cure aspirin, and medicines generally used in organ transplantation. presently, a significant portion of individuals at high threat for cardiovascular events take aspirin about 46 of women and 59 of men.

3. Renal and other major organ transplants:

Hyperuricemia and gout constantly do as complications in renal and other major solid-organ transplants. Transplant cases with hyperuricemia experience accelerated gouty common damage compared to those with primary hyperuricemia, and gout frequently affects multiple joints.

4. Dietary and Alcohol Consumption:

A study by Choi and colleagues investigated the relationship between gout and various dietary factors, including purine-rich foods, protein intake, and dairy consumption. The research involved 47,120 men without a history of gout at the start, and over 12 years, 730 new gout cases were confirmed.

5. Obesity:

The United States is facing a growing obesity epidemic, with approximately 60% of Americans currently overweight and childhood obesity rates rising alarmingly. BMI Available online http://arthritis-research.com/content/8/S1/S2 shows a significant correlation with gout riskr.⁴

Stages of Gout:⁵

Stages of Gout
Asymptomatic	Acute Intermittent Gout	Chronic Tophaceous Gout
Prior to first attack	Attacks begin, losting 3-10 days	Advance stage
Uric acid in blood causes urate to form crystals.	causes pain, swelling, stiffness, redness, fatigue, and sometimes fever.	Urate crystals form hardened lumps, eroding bone and cartilage

Pathophysiology:

Gout is a type of inflammatory arthritis characterized by recurring episodes of redness, tenderness, heat, and swelling in a joint. The pain associated with gout typically develops rapidly, within less than 12 hours. Gout results from a disorder in purine metabolism. Purines are ultimately converted to uric acid in the body, which crystallizes as mono-sodium urate. These crystals precipitate and form deposits called tophi in joints, tendons, and surrounding tissues. Microscopic tophi may be encased in a protein layer that prevents the crystal from interacting with cells, thus avoiding inflammation. This reaction activates the enzyme caspase 1, which transforms pro-interleukin 1 Beta into interleukin 1 Beta, a key protein in the inflammatory cascade.

· Sign and Symptoms:

The most prevalent manifestation of gout is characterized by intermittent episodes of acute inflammatory arthritis, which is typified by a red, tender, and heated joint, most frequently the metatarsophalangeal joint at the base of the hallux in affected individuals. Other commonly involved sites include the heels, knees, wrists, and ankles. The pain typically commences within a duration of 2 to 4 hours, often during nocturnal hours

1. Complications:

Following complications of gout can live:

Intermittent Gout:

Some people may no way witness gout signs and symptoms again. But other Any may witness gout several times each time. a drug may help gout attacks in people with intermittent gout.

Advanced Gout:

Undressed gout can beget deposit of Urate demitasse under the skin. Tophi can develop in several areas like fritters, hands, bases, elbows, tendons, and ankles. They can come blown and tender during attacks of gout.

Common fluid test:

The common fluid test is useful to observed uric acid demitasse are present. This is the only test for opinion of gout.

Blood test:

To measure the uric acid position in blood. Blood test results can be misleading through some people have high uric acid situations, but no way to witness gout. Some people have signs and symptoms of gout but don't have an unusual position of uric acid in their blood.

Urine test:

A test to measure the position of uric acid in urine.

X-rays:

X-rays of extremities are occasionally useful in the late stages of the complaint; X shafts aren't generally helpful in the early opinion. Pain frequently causes people to seek medical attention. big toe of affected.⁶

Diagnosis of Gout:

1. Positron emission tomograph (PET)

2. Clinical Diagnosis

3. Laboratory Diagnosis

4. Conventional Radiography

5. Conventional CT

6. Radiological Diagnosis

7. MRI

8. Ultrasound⁷

Herbal Treatment of Gout:

Example of drug use in gout treatment:

1. Compositae:

Blumea balsamifera is extensively distributed throughout Southeast Asia, including India It's used in folk drugs as a stomachic, expectorant, antispasmodic, antipyretic, and diaphoretic. The XO inhibitory conditioning of excerpt and insulated flavonoids from the leaves of the factory have been estimated in vitro. Conventionally, Helianthus annuus is used in contraception and gout-related complaints.

2. Cucurbitaceae:

The crushed leaves of Citrullus colocynthis are used topically for the treatment of gout. In addition to anti-gout properties, the factory is also used for nose bleeding, joint pains, skin conditions, rheumatism, and gastrointestinal problems. The XO inhibitory eventuality of methanolic excerpt of Coccinia grandis has been estimated in vitro.

3. Euphorbiaceae:

Euphorbia antiquorum, Jatropha curcas, and Tragia involucrata belong to the family Euphorbiaceae and are used in the traditional system of drugs for the treatment of gout. The cataplasm of roots of J. curcas is made into a paste and applied on the gout-affected corridor of the body. T. involucrata is also used in the treatment of bronchitis, asthma, venereal complaints, skin infections, and diabetes.⁸

CONCLUSION:

Gout has garnered significant attention due to its severe impact on health and quality of life. Numerous pharmacological studies have been conducted in vitro and in vivo using rat models. While several pharmacological mechanisms and XO inhibitory activities related to the kinetics of individual herbal extracts and chemical compounds have been identified as emerging evidence, the more detailed pharmacological mechanisms of synergistic combinations of herbs and chemical components require further clarification. Additionally, there is concern about the potential for medical resistance with prolonged use, highlighting the need for robust evidence from more clinical studies and applications to develop an effective herbal medicine formula for gout treatment.

REFERENCES:

1. The role of Western herbal medicine in the treatment of gout.

2. Effects and Mechanisms of Traditional Chinese Medicine and Related Active Constituents Treating Gout

3. Case series of 5 patients of gout: Management through Unani formulations (Habb-E-Suranjan) https

4. Epidemiology, risk factors, and lifestyle modifications for gout

5. https://images.app.goo.gl/eaQWgKEKWq8mtkzR8

6. Gout-a review on pathophysiology, etiology, and treament

7. Gout: causes and pharmaceutical issues

8. Indian medicinal plants useful in treatment of gout: a review for current status and future prospective

9. Herbal Drugs: To Take It or Not to Take It

Received on 25.04.2025 Revised on 24.06.2025

Accepted on 26.07.2025 Published on 04.10.2025

Available online from October 10, 2025

Asian J. Res. Pharm. Sci. 2025; 15(4):405-408.

DOI: 10.52711/2231-5659.2025.00060

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.